On April 26, more than 6,000 people participated in the 7th Annual Tar Heel 10 Miler
UNC Lineberger selected to join A Survivor Action Partnership to improve the lives of prostate cancer survivors
UNC Lineberger has been selected to participate in A Survivor Action Partnership – United States of America (ASAP USA), a consortium of institutions that will collaborate to develop and study interventions to improve the lives of prostate cancer survivors in the United States. Sixteen institutions were selected following a peer reviewed application process. Ronald Chen, MD, MPH, assistant professor of radiation oncology is leading the UNC Lineberger ASAP USA team.
The Leukemia & Lymphoma Society's Man & Woman of the Year (MWOY) campaign is a national fundraising competition in which participants vie for the title of Man or Woman of the Year. They raise funds for blood cancer research in honor of local children who are blood cancer survivors. The titles are awarded to the men and women who raise the most funds during the campaign in their communities. The top local fundraisers in the country also win the national titles.
Five questions for Chuck Perou, PhD, a UNC geneticist on the hunt for better treatments for the most deadly form of breast cancer
Cell movement plays an important role in a host of biological functions from embryonic development to repairing wounded tissue. It also enables cancer cells to break free from their sites of origin and migrate throughout the body.
UNC Lineberger member Deborah K. Mayer, PhD, RN, AOCN, FAAN, was awarded $50,000 in funding through the UNC School of Medicine’s Institute for Healthcare Quality Improvement seed grant program for her proposal “Implementing Survivorship Care Plans.”
Andrew Tucker, PhD, used his graduate experience at UNC to help build a new kind of mammographic imaging machine now in use in a clinical trial at the North Carolina Cancer Hospital.
The John William Pope Foundation has made a $1.3 million gift to UNC Lineberger Comprehensive Cancer Center to fund cancer research and treatment.
UNC Lineberger member Gary Johnson, PhD, professor and chair of the UNC Department of Pharmacology, has been tapped to join Synodos, a team of scientists working together to defeat the rare genetic disorder neurofibromatosis type 2 (NF2). A first-of-its-kind NF research collaboration, Synodos has brought together centers of excellence from institutions across the country. Johnson will be just one of 12 academic researchers in the collaboration.
Please join Team Lineberger for the Bladder Cancer Advocacy Network (BCAN) annual walk to raise awareness about bladder cancer on May 3, 2014 in Hillsborough, NC.